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Have we found the prevention for ICU-acquired paresis? 
In the previous issue of Critical Care, Seraﬁ  m Nanas and 
colleagues [1] presented a report of the use of trans  cu-
taneous electrical muscle stimulation (TEMS) in critically 
ill patients. Its simple application less than 1 hour a day 
resulted in improved global strength upon recovery. Th  e 
odds of developing ICU-acquired paresis were reduced 
by almost 80%. Importantly, there is precedent that this 
simple technology improves strength in other patient 
groups with at least partial immobilization [2] and the 
eﬀ  ect may be systemic [3].
Unfortunately, despite the magnitude of the observed 
eﬀ  ect in this patient population, many important ques-
tions remain unanswered. First, why would electrical 
stimu  lation of only the lower extremities impact overall 
strength? While systemic eﬀ   ects of TEMS have been 
observed in the form of improved microcirculation [3], is 
this enough to improve global strength in non-stimulated 
muscle groups? Severe sepsis, a disease long associated 
with a high rate of critical illness polyneuromyopathy, 
may actually lead to electrically unexcitable muscles [4,5]. 
Th   is particular study appears to have a relative minority 
of patients experiencing sepsis at ICU admission, leading 
to questions about its eﬃ   cacy in this population. Along 
these lines, the dose of electricity required to activate 
muscles in this study were not reported and several 
patients were not included in the analysis because they 
received no TEMS. Was this because capture could not be 
achieved or were they simply missed? For this speciﬁ  c 
question we await the results of studies focusing on the use 
of TEMS in sepsis patients (ClinicalTrials.gov identiﬁ  er 
NCT01071343).  Is it possible that TEMS at the doses 
used is mentally alerting? Th   is is an intriguing idea given 
that patients in the TEMS group in this study were less 
often excluded due to coma (11 in the TEMS group 
versus 22 in the control group) and therefore unable to be 
examined for strength. If this were true, it could explain 
why control patients could possibly remain in the ICU 
longer than their TEMS counterparts as the duration of 
time patients spend in coma is highly associated with the 
development of ICU-acquired weakness and muscle 
atrophy [6].
Additionally, what muscles should be targeted? Most 
recent studies of physical therapy interventions in the 
ICU have focused on ambulation [7,8]. However, respira-
tory muscle strength may be a more relevant target in 
respiratory failure patients. Extrapolating from out-
patient studies might suggest that a global approach to 
muscle training is important to achieve improved respira-
tory muscle strength [9]. Is it feasible to think that TEMS 
can be applied to both upper and lower extremities?
In fact, this article and the interpretation of its results 
raise signiﬁ  cant issues as to the essential data that need 
to be reported in studies of critically ill patients designed 
to measure physical strength as their outcome. Th   is is a 
very diﬀ  erent outcome than survival. Typical outcomes 
for interventions in severe sepsis patients have been 
survival or organ failure resolution [10,11]. However, in 
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Several recent reports have highlighted the utility 
of transcutaneous electrical muscle stimulation to 
preserve muscle mass and strength in ICU patients. 
Specifi  cally, Serafi  m Nanas and colleagues report 
a signifi  cant reduction in the odds of ICU-acquired 
weakness with its use. Whether these fi  ndings are 
relevant to all patients with acute respiratory failure 
remains to be seen. As critical care studies attempt to 
study the outcome of physical recovery, signifi  cant 
additional data need to be provided in order for the 
results to be reported in the appropriate context. 
Future studies need to be performed in a setting where 
secondary injuries like sedation and immobilization are 
quantifi  ed so any benefi  t can be weighed against other 
interventions available.
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accounted for. What is the baseline physical function of 
these ICU patients prior to their acute illness? How were 
sedative agents handled? What were the baseline physical 
therapy practices of the base ICU and, therefore, the 
control group? In many ways the example given to us by 
William Schweickert and colleagues [12] should serve as 
a guide for future researchers in this area of critical care 
research. In their study of structured physical therapy in 
ventilated patients, baseline functional status was deter-
mined and their intervention was applied in the context 
of rigorous sedation interruption ensuring that excess 
‘immobilization days’ were minimized. Similar to the 
studies of mechanical ventilation and weaning that 
require the standardization of multiple non-ventilator 
practices, future attempts to test interventions to 
preserve neuromuscular function in critically ill patients 
must account for these and other important co-factors.
While many questions remain regarding TEMS, there 
is little doubt that the present study represents an 
exciting new advance in our thinking on the ability to 
prevent severe neuromuscular injury in ICU patients. 
Much of our ability to include TEMS in the discussion of 
future therapies can be attributed to the multiple studies 
by Dr Nanas and colleagues. However, while TEMS is 
likely to play a role in the future, that role needs further 
deﬁ  nition. Th  e time for universal adoption is not upon 
us, but thoughtful application of these devices in future 
multi-centered studies could help to clarify the role of 
TEMS. Until then a concerted eﬀ   ort to avoid over-
sedation and provide the best physical therapy to all of 
our patients needs to be the priority.
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